BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9104904)

  • 1. Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation.
    Lee SH; Chen SA; Tai CT; Chiang CE; Wen ZC; Chen YJ; Yu WC; Huang JL; Fong AN; Cheng JJ; Chang MS
    Am J Cardiol; 1997 Apr; 79(7):905-8. PubMed ID: 9104904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
    Lee SH; Chen SA; Chiang CE; Tai CT; Wen ZC; Wang SP; Chang MS
    J Intern Med; 1996 Mar; 239(3):253-60. PubMed ID: 8772625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
    Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
    Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
    Bellandi F; Dabizzi RP; Niccoli L; Cantini F; Palchetti R
    G Ital Cardiol; 1996 Apr; 26(4):379-90. PubMed ID: 8707022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.
    Reimold SC; Cantillon CO; Friedman PL; Antman EM
    Am J Cardiol; 1993 Mar; 71(7):558-63. PubMed ID: 8438741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E; Denjoy I
    Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm?
    Kochiadakis GE; Marketou ME; Igoumenidis NE; Chrysostomakis SI; Mavrakis HE; Kaleboubas MD; Vardas PE
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1883-7. PubMed ID: 11139949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
    Freemantle N; Lafuente-Lafuente C; Mitchell S; Eckert L; Reynolds M
    Europace; 2011 Mar; 13(3):329-45. PubMed ID: 21227948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs.
    Antman EM; Beamer AD; Cantillon C; McGowan N; Friedman PL
    J Am Coll Cardiol; 1990 Mar; 15(3):698-707. PubMed ID: 2303641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of propafenone for recurrent paroxysmal atrial fibrillation.
    Connolly SJ; Hoffert DL
    Am J Cardiol; 1989 Apr; 63(12):817-9. PubMed ID: 2648787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery].
    Men EE; Yildirimtürk O; Tuğcu A; Aytekin V; Aytekin S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):206-12. PubMed ID: 18524727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
    Roy D; Talajic M; Dorian P; Connolly S; Eisenberg MJ; Green M; Kus T; Lambert J; Dubuc M; Gagné P; Nattel S; Thibault B
    N Engl J Med; 2000 Mar; 342(13):913-20. PubMed ID: 10738049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine.
    Lau CP; Chow MS; Tse HF; Tang MO; Fan C
    Am J Cardiol; 2000 Dec; 86(12):1327-32. PubMed ID: 11113407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
    Fresco C; Proclemer A; Pavan A; Buia G; Vicentini A; Pavan D; Morgera T
    Clin Cardiol; 1996 May; 19(5):409-12. PubMed ID: 8723601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation].
    Mihálcz A; Földesi C; Kardos A; Ladunga K; Szili-Török T
    Orv Hetil; 2009 Sep; 150(36):1694-700. PubMed ID: 19709984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation.
    Kochiadakis GE; Igoumenidis NE; Hamilos ME; Tzerakis PG; Klapsinos NC; Chlouverakis GI; Vardas PE
    Am J Cardiol; 2004 Dec; 94(12):1563-6. PubMed ID: 15589019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study.
    Azpitarte J; Alvarez M; Baún O; García R; Moreno E; Martín F; Tercedor L; Fernández R
    Eur Heart J; 1997 Oct; 18(10):1649-54. PubMed ID: 9347277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone.
    Wolk R; Kulakowski P; Karczmarewicz S; Karpinski G; Makowska E; Czepiel A; Ceremuzynski L
    Int J Cardiol; 1996 Jun; 54(3):207-11. PubMed ID: 8818742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators.
    Stroobandt R; Stiels B; Hoebrechts R
    Am J Cardiol; 1997 Feb; 79(4):418-23. PubMed ID: 9052343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.